Bringing a Leukemic Stem Cell Gene Signature into Clinics: Are We There Yet?
- PMID: 28257710
- DOI: 10.1016/j.stem.2017.02.010
Bringing a Leukemic Stem Cell Gene Signature into Clinics: Are We There Yet?
Abstract
Prognostic markers that capture leukemia stem cell (LSC) activity can be useful for the risk stratification of acute myeloid leukemia (AML) patients. In a recent issue of Nature, Ng et al. (2016) develop a prognostic score based on a 17-gene expression signature of LSCs to predict outcome in AML patients.
Copyright © 2017 Elsevier Inc. All rights reserved.
Comment on
-
A 17-gene stemness score for rapid determination of risk in acute leukaemia.Nature. 2016 Dec 15;540(7633):433-437. doi: 10.1038/nature20598. Epub 2016 Dec 7. Nature. 2016. PMID: 27926740
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
